Delivery Order SPE2DB24D9222-SPE2DB24FAZGJ
Award Date
8/28/24
Potential Completion Date
9/19/24
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The award, valued at $77,505.20, is for the supply of Keytruda 100 mg/4 ml vial to the Defense Logistics Agency (DLA), which supports the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order with a completion date of February 2, 2023. DMS Pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Keytruda 100 mg/4 ml vial (4 ml) to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award, valued at $96,342.84, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $120,428.55 to provide 4,566,597,117 units of Keytruda 100 mg/4 ml vial. The contract is a firm fixed-price award from the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. The contract, valued at $80,218.40, has an ultimate completion date of October 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which has a ceiling value...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities globally. This specific order is delivered under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Keytruda 100 mg/4 ml vials. The $48,171.42 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on August 8, 2024, with a completion date of August 29, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of January 30, 2024 and a potential value of $24,065.52. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with DLA to supply a variety of prescription...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supports the Department of Defense with a wide range of brand and generic prescription and over-the-counter drug supplies. This delivery order is part...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,142.85 firm fixed-price contract is for the supply of Keytruda 100 mg/4 ml vial. The contract has an ultimate completion date of July 3, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to...
This federal contract award is for the delivery of Keytruda 100 mg/4 ml vial, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $74,235.60 and an ultimate completion date of June 22, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery...